Extranodal Nk-t-cell Lymphoma Nasal and Nasal-type
📧 Sign up to get email alerts when something new happens for Extranodal Nk-t-cell Lymphoma Nasal and Nasal-type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL [Phase 2]
Phase 2 trial evaluating anti-PD-1 antibody plus P-GEMOX chemotherapy with radiotherapy for high-risk, early-stage Extranodal NK/T-Cell Lymp…
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL [Phase 2]
Phase 2 clinical trial update evaluating radiotherapy with anti-PD-1 therapy in low-risk extranodal NK/T-cell lymphoma, nasal type, in early…
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma [Phase 3]
Phase 3 clinical trial investigating PEG-ASP+Gemox and thalidomide for Extranodal NK/T-Cell Lymphoma, Nasal and Nasal-Type; status currently…